Following Borouge’s successful debut of its first-ever locally produced healthcare polypropylene product earlier this year, the company launched Bormed LE6607-PH – the first made-in-UAE low-density polyethylene (LDPE) for healthcare applications.

Borouge launched first made-in-UAE LDPE for pharmaceutical and medical packaging.

“This launch positions Borouge at the forefront of healthcare-grade production in the UAE, strengthening our leadership across the region. This strategic move not only supports diverse applications such as pharmaceutical manufacturing and patient care but also reinforces our commitment to innovation and regional growth,” said Hazeem Sultan Al Suwaidi, Chief Executive Officer of Borouge.

Leveraging Borealis’ established Bormed technology, Bormed LE6607-PH is an additive-free LDPE. The grade is optimized for purity, compliance, and stability, minimizing the level of extractables, leachables in final products and ensuring compatibility with aseptic processing standards.

The LDPE meets the stringent specifications of both the EU and US Pharmacopoeia, and is engineered for use in pharmaceutical and medical packaging, including IV bottles, blow-fill-seal bottles, ampoules, and other pharmaceutical packaging.

This launch builds on the successful introduction of Bormed RG868MO, Borouge’s first UAE-made healthcare product, and now extends the company’s healthcare portfolio even further. Together, these offerings reinforce Borouge’s role as a strategic enabler of medical innovation and national industrial capacity.

Following Borouge’s successful debut of its first-ever locally produced healthcare polypropylene product earlier this year, the company launched Bormed LE6607-PH – the first made-in-UAE low-density polyethylene (LDPE) for healthcare applications.

Borouge launched first made-in-UAE LDPE for pharmaceutical and medical packaging.

“This launch positions Borouge at the forefront of healthcare-grade production in the UAE, strengthening our leadership across the region. This strategic move not only supports diverse applications such as pharmaceutical manufacturing and patient care but also reinforces our commitment to innovation and regional growth,” said Hazeem Sultan Al Suwaidi, Chief Executive Officer of Borouge.

Leveraging Borealis’ established Bormed technology, Bormed LE6607-PH is an additive-free LDPE. The grade is optimized for purity, compliance, and stability, minimizing the level of extractables, leachables in final products and ensuring compatibility with aseptic processing standards.

The LDPE meets the stringent specifications of both the EU and US Pharmacopoeia, and is engineered for use in pharmaceutical and medical packaging, including IV bottles, blow-fill-seal bottles, ampoules, and other pharmaceutical packaging.

This launch builds on the successful introduction of Bormed RG868MO, Borouge’s first UAE-made healthcare product, and now extends the company’s healthcare portfolio even further. Together, these offerings reinforce Borouge’s role as a strategic enabler of medical innovation and national industrial capacity.